Your one point of contact for Actelion services and support
For Ventavis Patients
PAH Pathways Interactive Resource Locator
PAH Pathways offers a wealth of resources including one-on-one support from PAH Pathways counselors in your area.
Learn more ยป
If you are a patient taking Ventavis, PAH Pathways is here to help you on your journey with PAH.
PAH Pathways can:
- Help get you started on therapy
- Answer your insurance questions
- Connect you with financial assistance programs that may help you to pay for out-of-pocket costs
- Provide important education and support
- Provide training and support on the I-neb AAD System
I-neb AAD is a registered trademark of Philips Respironics.
Ventavis is indicated for the treatment of pulmonary arterial hypertension (WHO Group I) in patients with NYHA Class III or IV symptoms.
For help getting started on Ventavis therapy, click here.
Read Charlotte's story.
Ventavis is indicated for the treatment of pulmonary arterial hypertension (WHO Group I) in patients with NYHA Class III or IV symptoms.
Important safety information about Ventavis
Because it lowers your blood pressure, Ventavis may cause dizziness, lightheadedness, and fainting. With Ventavis, the most common side effects are reddening of the face caused by dilation of blood vessels (flushing), increased cough, low blood pressure (hypotension), headaches, nausea, spasm of the jaw muscles that causes trouble opening your mouth, and fainting (syncope); other serious adverse events reported with the use of Ventavis include congestive heart failure, chest pain, supraventricular tachycardia, dyspnea, peripheral edema, and kidney failure. Before you start taking Ventavis, talk to your doctor to make sure you understand the side effects you might get.
Please see accompanying full Prescribing Information.
Tracleer
Please see accompanying full Prescribing Information, including BOXED WARNING and Medication Guide for Tracleer.